Share Price and Basic Stock Data
Last Updated: December 15, 2025, 2:18 pm
| PEG Ratio | -29.47 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Hindcon Chemicals Ltd operates in the chemicals sector, focusing on niche products that cater to various industries. As of the latest reporting, the company’s stock price stood at ₹27.7, with a market capitalization of ₹142 Cr. Revenue trends reveal a mixed performance over the past few quarters. Sales peaked at ₹26.64 Cr in December 2022 but have since fluctuated, recording ₹19.25 Cr in March 2023 and dipping to ₹17.27 Cr in June 2023. The trailing twelve months (TTM) revenue was reported at ₹58.55 Cr, indicating a decline from the previous fiscal year’s ₹64.51 Cr. This inconsistency highlights the volatility in demand and possibly reflects broader economic conditions affecting the chemicals sector. Given the recent quarterly sales performance, it appears that Hindcon is navigating a challenging environment, which could be attributed to both internal operational issues and external market conditions.
Profitability and Efficiency Metrics
Profitability ratios for Hindcon Chemicals indicate a mixed bag, with operating profit margins (OPM) standing at 11.42%, which is relatively reasonable for the industry. However, the company has experienced fluctuations in net profit, with the latest recorded net profit at ₹3.85 Cr, translating to an earnings per share (EPS) of ₹1.00. The return on equity (ROE) was reported at 7.03%, which suggests that while the company is generating some returns for its shareholders, the level is below the optimal range for robust growth. Efficiency metrics, particularly the cash conversion cycle (CCC) of 108.51 days, seem stretched, indicating potential inefficiencies in managing working capital. The interest coverage ratio (ICR) of 79.32x, however, presents a strong position in terms of debt servicing capability, suggesting that while profitability is under pressure, the company is not over-leveraged.
Balance Sheet Strength and Financial Ratios
The balance sheet of Hindcon Chemicals reveals a cautious but stable financial standing. With total borrowings recorded at ₹6.18 Cr against reserves of ₹48.38 Cr, the company appears to be in a solid position, showcasing a low debt-to-equity ratio of 0.01. This indicates minimal reliance on external debt for financing operations, which is beneficial during economic downturns. Moreover, the current ratio of 5.36x suggests that the company is well-equipped to meet its short-term liabilities, reflecting strong liquidity. However, the price-to-book value (P/BV) ratio of 2.28x indicates that the stock may be priced at a premium compared to its book value, which could raise concerns among value investors. Overall, while the balance sheet appears robust, certain financial ratios suggest that the market may be pricing in growth expectations that the company has yet to fulfill.
Shareholding Pattern and Investor Confidence
Hindcon’s shareholding pattern reveals a significant level of promoter confidence, with promoters holding 68.71% of the company’s shares. This high level of ownership often suggests a strong alignment between management interests and those of shareholders. However, foreign institutional investors (FIIs) have not yet entered the stock, maintaining a 0.00% stake, which may indicate a lack of confidence from larger institutional players in the company’s growth trajectory. The public shareholding at 31.29% demonstrates a healthy level of retail participation, with the number of shareholders increasing to 29,663. This could suggest growing interest from retail investors, possibly due to the company’s perceived potential in a recovering market. Nevertheless, the absence of institutional backing may limit liquidity and could affect price stability in the long run.
Outlook, Risks, and Final Insight
Looking ahead, Hindcon Chemicals faces a blend of opportunities and risks. The company’s reliance on niche chemical markets could provide avenues for growth, particularly if demand rebounds. However, the volatility in recent sales figures and profitability metrics indicates that operational challenges may persist. Additionally, the absence of institutional investment could hinder future capital raising efforts, which might be necessary for scaling operations. Investors should remain cautious, as the fluctuating net profit and high cash conversion cycle suggest potential inefficiencies. With a strong balance sheet, Hindcon is well-positioned to weather short-term challenges, but the path to sustainable growth will require strategic focus and operational improvements. Investors might consider monitoring upcoming quarterly results closely to gauge whether the company can stabilize its earnings and enhance operational efficiency in a competitive landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Diamines & Chemicals Ltd | 256 Cr. | 262 | 537/250 | 158 | 0.38 % | 3.33 % | 1.78 % | 10.0 | |
| Deco-Mica Ltd | 27.1 Cr. | 64.5 | 97.0/56.0 | 14.8 | 64.2 | 0.00 % | 11.8 % | 7.51 % | 10.0 |
| Andhra Sugars Ltd | 1,045 Cr. | 77.1 | 100/64.9 | 13.1 | 121 | 1.04 % | 3.54 % | 2.51 % | 2.00 |
| Tamil Nadu Petro Products Ltd | 939 Cr. | 104 | 130/63.6 | 9.38 | 109 | 1.15 % | 6.97 % | 5.10 % | 10.0 |
| SRF Ltd | 89,627 Cr. | 3,024 | 3,325/2,197 | 55.4 | 447 | 0.24 % | 12.3 % | 10.4 % | 10.0 |
| Industry Average | 14,568.67 Cr | 1,186.70 | 33.31 | 204.33 | 0.41% | 10.57% | 8.89% | 7.60 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21.06 | 18.64 | 26.64 | 19.25 | 17.27 | 19.46 | 13.44 | 14.34 | 12.91 | 12.96 | 15.27 | 15.44 | 14.88 |
| Expenses | 19.79 | 18.19 | 24.86 | 17.59 | 14.18 | 18.44 | 12.25 | 12.55 | 11.18 | 12.71 | 14.06 | 14.40 | 13.18 |
| Operating Profit | 1.27 | 0.45 | 1.78 | 1.66 | 3.09 | 1.02 | 1.19 | 1.79 | 1.73 | 0.25 | 1.21 | 1.04 | 1.70 |
| OPM % | 6.03% | 2.41% | 6.68% | 8.62% | 17.89% | 5.24% | 8.85% | 12.48% | 13.40% | 1.93% | 7.92% | 6.74% | 11.42% |
| Other Income | 0.23 | 0.42 | 0.27 | 0.27 | 0.41 | 0.31 | 0.29 | 0.67 | 0.35 | 0.74 | 0.86 | -0.05 | 0.43 |
| Interest | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.03 | 0.01 | 0.02 | 0.00 | 0.02 | 0.01 | 0.05 | 0.04 |
| Depreciation | 0.07 | 0.07 | 0.07 | 0.08 | 0.06 | 0.07 | 0.08 | 0.14 | 0.19 | 0.20 | 0.20 | 0.23 | 0.21 |
| Profit before tax | 1.42 | 0.79 | 1.96 | 1.84 | 3.43 | 1.23 | 1.39 | 2.30 | 1.89 | 0.77 | 1.86 | 0.71 | 1.88 |
| Tax % | 28.17% | 31.65% | 27.55% | 26.63% | 25.66% | 30.08% | 27.34% | 21.74% | 30.16% | 23.38% | 25.81% | 22.54% | 28.19% |
| Net Profit | 1.04 | 0.54 | 1.41 | 1.36 | 2.55 | 0.88 | 1.01 | 1.80 | 1.31 | 0.58 | 1.37 | 0.55 | 1.35 |
| EPS in Rs | 0.20 | 0.11 | 0.27 | 0.26 | 0.49 | 0.17 | 0.20 | 0.35 | 0.25 | 0.11 | 0.27 | 0.11 | 0.26 |
Last Updated: August 20, 2025, 9:40 am
Below is a detailed analysis of the quarterly data for Hindcon Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 14.88 Cr.. The value appears to be declining and may need further review. It has decreased from 15.44 Cr. (Mar 2025) to 14.88 Cr., marking a decrease of 0.56 Cr..
- For Expenses, as of Jun 2025, the value is 13.18 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 14.40 Cr. (Mar 2025) to 13.18 Cr., marking a decrease of 1.22 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.70 Cr.. The value appears strong and on an upward trend. It has increased from 1.04 Cr. (Mar 2025) to 1.70 Cr., marking an increase of 0.66 Cr..
- For OPM %, as of Jun 2025, the value is 11.42%. The value appears strong and on an upward trend. It has increased from 6.74% (Mar 2025) to 11.42%, marking an increase of 4.68%.
- For Other Income, as of Jun 2025, the value is 0.43 Cr.. The value appears strong and on an upward trend. It has increased from -0.05 Cr. (Mar 2025) to 0.43 Cr., marking an increase of 0.48 Cr..
- For Interest, as of Jun 2025, the value is 0.04 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.05 Cr. (Mar 2025) to 0.04 Cr., marking a decrease of 0.01 Cr..
- For Depreciation, as of Jun 2025, the value is 0.21 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.23 Cr. (Mar 2025) to 0.21 Cr., marking a decrease of 0.02 Cr..
- For Profit before tax, as of Jun 2025, the value is 1.88 Cr.. The value appears strong and on an upward trend. It has increased from 0.71 Cr. (Mar 2025) to 1.88 Cr., marking an increase of 1.17 Cr..
- For Tax %, as of Jun 2025, the value is 28.19%. The value appears to be increasing, which may not be favorable. It has increased from 22.54% (Mar 2025) to 28.19%, marking an increase of 5.65%.
- For Net Profit, as of Jun 2025, the value is 1.35 Cr.. The value appears strong and on an upward trend. It has increased from 0.55 Cr. (Mar 2025) to 1.35 Cr., marking an increase of 0.80 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.26. The value appears strong and on an upward trend. It has increased from 0.11 (Mar 2025) to 0.26, marking an increase of 0.15.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:15 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 32.83 | 32.34 | 33.81 | 35.28 | 44.40 | 44.07 | 44.27 | 66.62 | 85.59 | 64.51 | 56.59 | 60.91 |
| Expenses | 33.30 | 30.24 | 30.20 | 30.49 | 40.65 | 40.55 | 39.71 | 61.63 | 80.42 | 57.41 | 52.35 | 56.21 |
| Operating Profit | -0.47 | 2.10 | 3.61 | 4.79 | 3.75 | 3.52 | 4.56 | 4.99 | 5.17 | 7.10 | 4.24 | 4.70 |
| OPM % | -1.43% | 6.49% | 10.68% | 13.58% | 8.45% | 7.99% | 10.30% | 7.49% | 6.04% | 11.01% | 7.49% | 7.72% |
| Other Income | 2.03 | 0.09 | 0.35 | 0.98 | 0.57 | 1.00 | 2.15 | 1.37 | 1.19 | 1.68 | 1.89 | 1.79 |
| Interest | 0.79 | 0.68 | 0.67 | 0.52 | 0.23 | 0.09 | 0.08 | 0.02 | 0.05 | 0.08 | 0.08 | 0.20 |
| Depreciation | 0.27 | 0.21 | 0.18 | 0.14 | 0.13 | 0.14 | 0.18 | 0.25 | 0.29 | 0.35 | 0.82 | 0.87 |
| Profit before tax | 0.50 | 1.30 | 3.11 | 5.11 | 3.96 | 4.29 | 6.45 | 6.09 | 6.02 | 8.35 | 5.23 | 5.42 |
| Tax % | 32.00% | 34.62% | 32.80% | 22.31% | 28.03% | 33.33% | 25.89% | 30.05% | 27.74% | 25.39% | 26.58% | |
| Net Profit | 0.34 | 0.85 | 2.09 | 3.98 | 2.82 | 2.84 | 4.77 | 4.26 | 4.36 | 6.23 | 3.83 | 3.99 |
| EPS in Rs | 0.45 | 1.12 | 2.76 | 0.78 | 0.55 | 0.55 | 0.92 | 0.83 | 0.84 | 1.21 | 0.74 | 0.78 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 16.32% | 24.31% | 24.32% | 30.83% | 0.00% | 12.41% | 60.55% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 150.00% | 145.88% | 90.43% | -29.15% | 0.71% | 67.96% | -10.69% | 2.35% | 42.89% | -38.52% |
| Change in YoY Net Profit Growth (%) | 0.00% | -4.12% | -55.45% | -119.58% | 29.85% | 67.25% | -78.65% | 13.04% | 40.54% | -81.41% |
Hindcon Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 5% |
| 3 Years: | -5% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 6% |
| 3 Years: | -3% |
| TTM: | -23% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 57% |
| 3 Years: | 30% |
| 1 Year: | -40% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 11% |
| 3 Years: | 10% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 6:10 am
Balance Sheet
Last Updated: December 4, 2025, 1:22 am
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.76 | 0.76 | 0.85 | 10.24 | 7.67 | 7.67 | 7.67 | 7.67 | 7.67 | 7.67 | 7.67 | 7.67 |
| Reserves | 10.69 | 11.50 | 14.23 | 15.47 | 22.42 | 24.67 | 27.78 | 31.47 | 34.68 | 42.28 | 46.35 | 48.38 |
| Borrowings | 8.92 | 5.28 | 5.02 | 0.82 | 0.18 | 0.30 | 0.99 | 1.24 | 0.98 | 0.00 | 0.77 | 6.18 |
| Other Liabilities | 4.43 | 6.30 | 5.94 | 6.60 | 5.95 | 6.73 | 6.78 | 12.23 | 10.31 | 9.62 | 8.79 | 10.15 |
| Total Liabilities | 24.80 | 23.84 | 26.04 | 33.13 | 36.22 | 39.37 | 43.22 | 52.61 | 53.64 | 59.57 | 63.58 | 72.38 |
| Fixed Assets | 0.93 | 0.92 | 1.11 | 1.08 | 1.00 | 1.13 | 1.41 | 1.72 | 2.57 | 6.25 | 7.11 | 7.78 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.39 | 0.00 | 0.00 | 0.00 |
| Investments | 0.28 | 0.66 | 0.81 | 3.24 | 4.32 | 4.47 | 2.79 | 3.21 | 2.19 | 4.66 | 4.76 | 4.78 |
| Other Assets | 23.59 | 22.26 | 24.12 | 28.81 | 30.90 | 33.77 | 39.02 | 47.68 | 48.49 | 48.66 | 51.71 | 59.82 |
| Total Assets | 24.80 | 23.84 | 26.04 | 33.13 | 36.22 | 39.37 | 43.22 | 52.61 | 53.64 | 59.57 | 63.58 | 72.38 |
Below is a detailed analysis of the balance sheet data for Hindcon Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 7.67 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.67 Cr..
- For Reserves, as of Sep 2025, the value is 48.38 Cr.. The value appears strong and on an upward trend. It has increased from 46.35 Cr. (Mar 2025) to 48.38 Cr., marking an increase of 2.03 Cr..
- For Borrowings, as of Sep 2025, the value is 6.18 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.77 Cr. (Mar 2025) to 6.18 Cr., marking an increase of 5.41 Cr..
- For Other Liabilities, as of Sep 2025, the value is 10.15 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.79 Cr. (Mar 2025) to 10.15 Cr., marking an increase of 1.36 Cr..
- For Total Liabilities, as of Sep 2025, the value is 72.38 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 63.58 Cr. (Mar 2025) to 72.38 Cr., marking an increase of 8.80 Cr..
- For Fixed Assets, as of Sep 2025, the value is 7.78 Cr.. The value appears strong and on an upward trend. It has increased from 7.11 Cr. (Mar 2025) to 7.78 Cr., marking an increase of 0.67 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 4.78 Cr.. The value appears strong and on an upward trend. It has increased from 4.76 Cr. (Mar 2025) to 4.78 Cr., marking an increase of 0.02 Cr..
- For Other Assets, as of Sep 2025, the value is 59.82 Cr.. The value appears strong and on an upward trend. It has increased from 51.71 Cr. (Mar 2025) to 59.82 Cr., marking an increase of 8.11 Cr..
- For Total Assets, as of Sep 2025, the value is 72.38 Cr.. The value appears strong and on an upward trend. It has increased from 63.58 Cr. (Mar 2025) to 72.38 Cr., marking an increase of 8.80 Cr..
Notably, the Reserves (48.38 Cr.) exceed the Borrowings (6.18 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -9.39 | -3.18 | -1.41 | 3.97 | 3.57 | 3.22 | 3.57 | 3.75 | 4.19 | 7.10 | 3.47 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 199.90 | 204.51 | 199.50 | 189.43 | 159.56 | 164.24 | 158.38 | 144.42 | 111.65 | 125.83 | 139.38 |
| Inventory Days | 17.87 | 18.30 | 13.08 | 43.62 | 28.94 | 22.98 | 21.77 | 24.26 | 17.35 | 12.03 | 18.18 |
| Days Payable | 41.21 | 60.55 | 50.92 | 55.52 | 39.08 | 54.34 | 50.63 | 53.69 | 38.78 | 42.55 | 49.05 |
| Cash Conversion Cycle | 176.57 | 162.27 | 161.66 | 177.53 | 149.42 | 132.88 | 129.53 | 115.00 | 90.22 | 95.32 | 108.51 |
| Working Capital Days | 193.45 | 169.41 | 128.68 | 169.67 | 189.98 | 198.19 | 159.46 | 152.75 | 114.63 | 128.27 | 148.15 |
| ROCE % | 10.43% | 19.92% | 21.20% | 14.70% | 13.98% | 18.85% | 15.69% | 14.34% | 17.87% | 9.97% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.00 | 1.62 | 5.68 | 5.56 | 5.89 |
| Diluted EPS (Rs.) | 1.00 | 1.62 | 5.68 | 5.56 | 5.89 |
| Cash EPS (Rs.) | 1.21 | 1.72 | 6.05 | 5.89 | 6.19 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 14.08 | 13.18 | 55.83 | 51.61 | 47.51 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 14.08 | 13.18 | 55.83 | 51.61 | 47.51 |
| Revenue From Operations / Share (Rs.) | 14.75 | 16.82 | 111.57 | 86.83 | 57.85 |
| PBDIT / Share (Rs.) | 1.60 | 2.29 | 8.29 | 8.30 | 8.59 |
| PBIT / Share (Rs.) | 1.38 | 2.20 | 7.92 | 7.97 | 8.34 |
| PBT / Share (Rs.) | 1.36 | 2.18 | 7.85 | 7.94 | 8.32 |
| Net Profit / Share (Rs.) | 0.99 | 1.62 | 5.68 | 5.56 | 5.95 |
| NP After MI And SOA / Share (Rs.) | 0.99 | 1.61 | 5.63 | 5.51 | 5.89 |
| PBDIT Margin (%) | 10.82 | 13.61 | 7.43 | 9.55 | 14.84 |
| PBIT Margin (%) | 9.37 | 13.06 | 7.09 | 9.17 | 14.42 |
| PBT Margin (%) | 9.23 | 12.94 | 7.03 | 9.14 | 14.39 |
| Net Profit Margin (%) | 6.76 | 9.66 | 5.08 | 6.39 | 10.28 |
| NP After MI And SOA Margin (%) | 6.71 | 9.58 | 5.04 | 6.35 | 10.18 |
| Return on Networth / Equity (%) | 7.03 | 12.37 | 10.19 | 10.80 | 12.50 |
| Return on Capital Employeed (%) | 9.57 | 16.57 | 14.06 | 15.42 | 17.42 |
| Return On Assets (%) | 5.95 | 10.37 | 8.05 | 8.04 | 10.15 |
| Total Debt / Equity (X) | 0.01 | 0.00 | 0.02 | 0.03 | 0.02 |
| Asset Turnover Ratio (%) | 0.91 | 1.14 | 1.61 | 1.35 | 1.09 |
| Current Ratio (X) | 5.36 | 4.95 | 4.56 | 3.56 | 4.83 |
| Quick Ratio (X) | 5.13 | 4.77 | 4.24 | 3.29 | 4.57 |
| Inventory Turnover Ratio (X) | 32.11 | 13.20 | 14.54 | 11.99 | 11.21 |
| Dividend Payout Ratio (NP) (%) | 10.19 | 6.27 | 12.43 | 45.54 | 15.26 |
| Dividend Payout Ratio (CP) (%) | 8.38 | 5.93 | 11.65 | 42.97 | 14.66 |
| Earning Retention Ratio (%) | 89.81 | 93.73 | 87.57 | 54.46 | 84.74 |
| Cash Earning Retention Ratio (%) | 91.62 | 94.07 | 88.35 | 57.03 | 85.34 |
| Interest Coverage Ratio (X) | 79.32 | 116.14 | 126.44 | 284.21 | 447.20 |
| Interest Coverage Ratio (Post Tax) (X) | 50.61 | 83.43 | 87.60 | 191.32 | 310.80 |
| Enterprise Value (Cr.) | 110.57 | 188.47 | 51.83 | 49.65 | 9.63 |
| EV / Net Operating Revenue (X) | 1.95 | 2.92 | 0.60 | 0.74 | 0.21 |
| EV / EBITDA (X) | 18.06 | 21.47 | 8.15 | 7.80 | 1.46 |
| MarketCap / Net Operating Revenue (X) | 2.18 | 3.10 | 0.70 | 0.80 | 0.42 |
| Retention Ratios (%) | 89.80 | 93.72 | 87.56 | 54.45 | 84.73 |
| Price / BV (X) | 2.28 | 4.00 | 1.43 | 1.36 | 0.51 |
| Price / Net Operating Revenue (X) | 2.18 | 3.10 | 0.70 | 0.80 | 0.42 |
| EarningsYield | 0.03 | 0.03 | 0.07 | 0.07 | 0.24 |
After reviewing the key financial ratios for Hindcon Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.00. This value is below the healthy minimum of 5. It has decreased from 1.62 (Mar 24) to 1.00, marking a decrease of 0.62.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.00. This value is below the healthy minimum of 5. It has decreased from 1.62 (Mar 24) to 1.00, marking a decrease of 0.62.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.21. This value is below the healthy minimum of 3. It has decreased from 1.72 (Mar 24) to 1.21, marking a decrease of 0.51.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.08. It has increased from 13.18 (Mar 24) to 14.08, marking an increase of 0.90.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.08. It has increased from 13.18 (Mar 24) to 14.08, marking an increase of 0.90.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 14.75. It has decreased from 16.82 (Mar 24) to 14.75, marking a decrease of 2.07.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.60. This value is below the healthy minimum of 2. It has decreased from 2.29 (Mar 24) to 1.60, marking a decrease of 0.69.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.38. This value is within the healthy range. It has decreased from 2.20 (Mar 24) to 1.38, marking a decrease of 0.82.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.36. This value is within the healthy range. It has decreased from 2.18 (Mar 24) to 1.36, marking a decrease of 0.82.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.99. This value is below the healthy minimum of 2. It has decreased from 1.62 (Mar 24) to 0.99, marking a decrease of 0.63.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.99. This value is below the healthy minimum of 2. It has decreased from 1.61 (Mar 24) to 0.99, marking a decrease of 0.62.
- For PBDIT Margin (%), as of Mar 25, the value is 10.82. This value is within the healthy range. It has decreased from 13.61 (Mar 24) to 10.82, marking a decrease of 2.79.
- For PBIT Margin (%), as of Mar 25, the value is 9.37. This value is below the healthy minimum of 10. It has decreased from 13.06 (Mar 24) to 9.37, marking a decrease of 3.69.
- For PBT Margin (%), as of Mar 25, the value is 9.23. This value is below the healthy minimum of 10. It has decreased from 12.94 (Mar 24) to 9.23, marking a decrease of 3.71.
- For Net Profit Margin (%), as of Mar 25, the value is 6.76. This value is within the healthy range. It has decreased from 9.66 (Mar 24) to 6.76, marking a decrease of 2.90.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.71. This value is below the healthy minimum of 8. It has decreased from 9.58 (Mar 24) to 6.71, marking a decrease of 2.87.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.03. This value is below the healthy minimum of 15. It has decreased from 12.37 (Mar 24) to 7.03, marking a decrease of 5.34.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.57. This value is below the healthy minimum of 10. It has decreased from 16.57 (Mar 24) to 9.57, marking a decrease of 7.00.
- For Return On Assets (%), as of Mar 25, the value is 5.95. This value is within the healthy range. It has decreased from 10.37 (Mar 24) to 5.95, marking a decrease of 4.42.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.91. It has decreased from 1.14 (Mar 24) to 0.91, marking a decrease of 0.23.
- For Current Ratio (X), as of Mar 25, the value is 5.36. This value exceeds the healthy maximum of 3. It has increased from 4.95 (Mar 24) to 5.36, marking an increase of 0.41.
- For Quick Ratio (X), as of Mar 25, the value is 5.13. This value exceeds the healthy maximum of 2. It has increased from 4.77 (Mar 24) to 5.13, marking an increase of 0.36.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 32.11. This value exceeds the healthy maximum of 8. It has increased from 13.20 (Mar 24) to 32.11, marking an increase of 18.91.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 10.19. This value is below the healthy minimum of 20. It has increased from 6.27 (Mar 24) to 10.19, marking an increase of 3.92.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 8.38. This value is below the healthy minimum of 20. It has increased from 5.93 (Mar 24) to 8.38, marking an increase of 2.45.
- For Earning Retention Ratio (%), as of Mar 25, the value is 89.81. This value exceeds the healthy maximum of 70. It has decreased from 93.73 (Mar 24) to 89.81, marking a decrease of 3.92.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 91.62. This value exceeds the healthy maximum of 70. It has decreased from 94.07 (Mar 24) to 91.62, marking a decrease of 2.45.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 79.32. This value is within the healthy range. It has decreased from 116.14 (Mar 24) to 79.32, marking a decrease of 36.82.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 50.61. This value is within the healthy range. It has decreased from 83.43 (Mar 24) to 50.61, marking a decrease of 32.82.
- For Enterprise Value (Cr.), as of Mar 25, the value is 110.57. It has decreased from 188.47 (Mar 24) to 110.57, marking a decrease of 77.90.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.95. This value is within the healthy range. It has decreased from 2.92 (Mar 24) to 1.95, marking a decrease of 0.97.
- For EV / EBITDA (X), as of Mar 25, the value is 18.06. This value exceeds the healthy maximum of 15. It has decreased from 21.47 (Mar 24) to 18.06, marking a decrease of 3.41.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.18. This value is within the healthy range. It has decreased from 3.10 (Mar 24) to 2.18, marking a decrease of 0.92.
- For Retention Ratios (%), as of Mar 25, the value is 89.80. This value exceeds the healthy maximum of 70. It has decreased from 93.72 (Mar 24) to 89.80, marking a decrease of 3.92.
- For Price / BV (X), as of Mar 25, the value is 2.28. This value is within the healthy range. It has decreased from 4.00 (Mar 24) to 2.28, marking a decrease of 1.72.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.18. This value is within the healthy range. It has decreased from 3.10 (Mar 24) to 2.18, marking a decrease of 0.92.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Hindcon Chemicals Ltd:
- Net Profit Margin: 6.76%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.57% (Industry Average ROCE: 10.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.03% (Industry Average ROE: 8.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 50.61
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 5.13
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 36.4 (Industry average Stock P/E: 29.98)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.76%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Others | No: 62/B, Braunfeld Row, Kolkata West Bengal 700027 | contactus@hindcon.com www.hindcon.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sanjay Goenka | Chairman & Managing Director |
| Mrs. Nilima Goenka | Whole Time Director |
| Mr. Ramsanatan Banerjee | Whole Time Director |
| Mr. Binay Kumar Agarwal | Independent Director |
| Ms. Divyaa Newatia | Independent Director |
| Mr. Girdhari Lal Goenka | Independent Director |
FAQ
What is the intrinsic value of Hindcon Chemicals Ltd?
Hindcon Chemicals Ltd's intrinsic value (as of 15 December 2025) is 23.75 which is 16.37% lower the current market price of 28.40, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 145 Cr. market cap, FY2025-2026 high/low of 50.0/27.0, reserves of ₹48.38 Cr, and liabilities of 72.38 Cr.
What is the Market Cap of Hindcon Chemicals Ltd?
The Market Cap of Hindcon Chemicals Ltd is 145 Cr..
What is the current Stock Price of Hindcon Chemicals Ltd as on 15 December 2025?
The current stock price of Hindcon Chemicals Ltd as on 15 December 2025 is 28.4.
What is the High / Low of Hindcon Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Hindcon Chemicals Ltd stocks is 50.0/27.0.
What is the Stock P/E of Hindcon Chemicals Ltd?
The Stock P/E of Hindcon Chemicals Ltd is 36.4.
What is the Book Value of Hindcon Chemicals Ltd?
The Book Value of Hindcon Chemicals Ltd is 11.0.
What is the Dividend Yield of Hindcon Chemicals Ltd?
The Dividend Yield of Hindcon Chemicals Ltd is 0.00 %.
What is the ROCE of Hindcon Chemicals Ltd?
The ROCE of Hindcon Chemicals Ltd is 9.97 %.
What is the ROE of Hindcon Chemicals Ltd?
The ROE of Hindcon Chemicals Ltd is 7.27 %.
What is the Face Value of Hindcon Chemicals Ltd?
The Face Value of Hindcon Chemicals Ltd is 2.00.